Research Paper Volume 16, Issue 11 pp 10142—10164
Prognostic implication and immunotherapy response prediction of a novel ubiquitination-related gene signature in liver cancer
Figure 4. Validation of the risk signature. Survival analysis using the K-M method was performed on three different sets: the TCGA-test set (A, D), the TCGA-all set (B, E), and the ICGC-LIRI-JP set (C, F). To assess the precision of the signature, we utilized ROC curves for 1-, 3-, and 5-year intervals.